To Mars Wrigley, Getting High on ‘Medicated’ Skittles Is No Joke
(Bloomberg) -- Mars Inc.'s Wrigley unit, owner of the Skittles, Starburst and Life Savers brands, sued the owners of several online shops to block them from selling THC-infused products that infringe trademarks for the candy maker's iconic products.
Wrigley cited the sale of “Medicated Skittles,” “Starburst Gummies” and “Life Savers Medicated Gummies” as examples of what it said were trademark infringement and dilution, and unfair competition.
The candies “pose a great danger to the public as anyone, children and adults alike, could easily mistake the infringing cannabis-infused products for Wrigley's famous and beloved candies and inadvertently ingest” the THC in them, according to a complaint filed Monday in federal court in Riverside, California.
The packaged products, which are infused with cannabis's main psychoactive ingredient, “nearly-identically resemble” the Wrigley candies, the suit claims.
The complaint names as defendants the California-based owners of websites called 2020ediblez.com, ie420supply.com and oc420collection.com, among others. Several of the defendants didn't return calls and emails seeking comment.
Mars, which also filed suit in Canada, seeks damages of $2 million per counterfeit mark for each type of candy sold, and it wants all profits from the infringing sales and the destruction of all infringing products.
Wrigley said it has previously sued the makers and sellers of “‘candy-flavored' e-liquid products for e-cigarettes when those products presented a risk of harm to children and the public at large.”
The case is Wm. Wrigley Jr. Co. v. Conde, 5:21-cv-777, U.S. District Court, Central District of California (Eastern Division -- Riverside).
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.